Targeted pain relief without the side effects of traditional opioids is driving interest in painkilling peptides. These short amino acid chains, like those derived from cone snail venom, work by blocking specific nerve signals. Used in clinical trials and research for chronic and neuropathic pain, they offer hope for patients seeking alternatives to conventional medication.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends